Global Study on IBD published in The Lancet
This first comprehensive global study of “Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies” shows that inflammatory bowel disease (IBD), previously mainly prevalent in Western countries, has become a global disease with rapidly rising incidence in newly industrialized countries of Asia and South America. (Lancet. 2017 October 16. doi: 10.1016/S0140-6736(17)32448-0 [Epub ahead of print])
To help those newly industrialized countries prepare their clinical infrastructure and personnel to deal with this costly disease, Prof Siew Ng and her team currently have three studies in progress in search of a coordinated solution to prevent and treat IBD. Anyone interested in future collaboration in this field of research is welcome to contact our key investigator Prof Siew Ng of our Department of Medicine and Therapeutics. Prof Ng’s research interests focus on epidemiological, genetics and microbiota studies in inflammatory bowel diseases.
Full article: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32448-0/fulltext?rss=yes